CureVac said that its production deals with Rentschler Biopharma and Novartis will remain in place. Read More

Two outgoing vaccine experts at the FDA as well as experts from the World Health Organization (WHO) are arguing that providing COVID-19 booster shots to the general public isn’t warranted at this time. Read More

Moderna is working on a new booster vaccine, mRNA-1073, that combines the drugmaker’s COVID-19 shot with its experimental flu vaccine in a single dose. Read More

“We need to fight today’s pandemic but also ensure we are prepared with new drugs to combat viruses with future pandemic potential,” said Exscientia CEO Andrew Hopkins. Read More

Approved vaccines and the diminishing numbers of unexposed individuals are making placebo-controlled trials for COVID-19 vaccines a thing of the past, so researchers will have to rely on active comparators to develop second-generation shots. Read More

The Biden administration has pledged to pour almost $3 billion into beefing up domestic COVID-19 vaccine manufacturing as it considers a potential mass program of booster shots. Read More

The Biden administration’s plan for a Sept. 20 rollout of vaccine booster shots may be delayed as the FDA and the Centers for Disease Control and Prevention (CDC) consider the available data for the Pfizer/BioNTech, Moderna and Johnson & Johnson (J&J) boosters. Read More

The FDA is deliberating between approving a booster shot of Moderna’s COVID-19 vaccine at a 50 microgram (mcg) level or at a current 100 mcg level, the latter being the level that make up the first two doses each of the vaccine. Read More

The FDA announced that it will hold an advisory committee meeting Sept. 17 to discuss the third booster for the Pfizer/BioNTech mRNA COVID-19 vaccine for people age 16 years and older. Read More

A county judge in Ohio has issued a court order forcing a Cincinnati hospital to give the anti-parasitic ivermectin for three weeks to a man suffering with COVID-19. Read More